Telapristone
Lua error in Module:Infobox at line 314: malformed pattern (missing ']').
Telapristone (INN), as telapristone acetate (proposed trade names Proellex, Progenta; former code name CDB-4124), is an investigational selective progesterone receptor modulator (SPRM) being studied for the treatment of certain progesterone-sensitive conditions.[1] It was originally developed by the National Institutes of Health (NIH), and as of 2012, is in phase II clinical trials for the treatment of uterine fibroids and endometriosis.[2] In addition to its actions as an SPRM, telapristone also has some antiglucocorticoid activity.[citation needed]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." /><templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ ClinicalTrials.gov
- Pages with reference errors
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugboxes with an unspecified ATC code
- Articles with unsourced statements from May 2012
- Acetate esters
- Antiglucocorticoids
- Hormonal agents
- Progestogens
- Steroids
- Genito-urinary system drug stubs
